Quidel coronavirus test granted emergency authorization

2020 01 27 21 38 4451 Lab 2019 Coronavirus Test 400

Quidel has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to market its Lyra SARS-CoV-2 assay, a real-time reverse transcription polymerase chain reaction (RT-PCR) test for the novel coronavirus.

Quidel's Lyra line of products also includes PCR reagent kits. The Lyra SARS-CoV-2 assay is currently only available in the U.S., and it can be purchased through Quidel or Cardinal Health, the company said.

Page 1 of 23
Next Page